Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500097831Phase 4Not yet recruiting
Phase 4, randomised trial of remimazolam in Neck Of Femur Fracture and osteonecrosis of the hip (2 arms), sponsored by Hefei BOE Hospital. Primary endpoint: Tracheal catheter removal time. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500097831.